|Slideshows|August 30, 2019

Common hereditary cancer syndromes with breast and gynecologic malignancies

Author(s)Susan C. Modesitt, MD, Christine Garcia, MD

As they often serve as primary care providers, ob/gyns are uniquely positioned to help identify at-risk women before they develop cancer.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Brexanolone shows rapid, sustained relief in postpartum depression

ByMelanie Barrett, MD

December 9th 2025

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

ByJoyce Slingerland, MD, PhD

December 9th 2025

Justin Drake, PhD, discusses the latest research on a protein-based liquid biopsy to detect early breast cancer

ByJustin Drake, PhD

December 9th 2025

Matthew Nudy, MD, discusses breast arterial calcification and cardiovascular risk

ByMatthew Nudy, MD

December 8th 2025

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

ByGenevieve Neal-Perry, MD, PhD

December 8th 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Common hereditary cancer syndromes with breast and gynecologic malignancies

Newsletter

Related Content

Brexanolone shows rapid, sustained relief in postpartum depression

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

Justin Drake, PhD, discusses the latest research on a protein-based liquid biopsy to detect early breast cancer

Matthew Nudy, MD, discusses breast arterial calcification and cardiovascular risk

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Justin Drake, PhD, discusses the latest research on a protein-based liquid biopsy to detect early breast cancer

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

Brexanolone shows rapid, sustained relief in postpartum depression

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

Beyond Vasomotor Symptoms: The Potential Role of NK Receptor Antagonism in Mood and Sleep